Omega Healthcare Investors Q3FY26 Results: Earnings date set for Nov 3
- Omega Healthcare Investors will report Q3 2026 earnings on November 3, 2026
- Conference call scheduled for November 4 at 10 am ET
- Webcast and telephone access details provided for investors
- Replays available for two weeks post-call

*this image is generated using AI for illustrative purposes only.
Omega Healthcare Investors (NYSE: OHI) announced it will release third quarter 2026 earnings results on November 3, 2026, after market close. The company also scheduled a conference call for November 4, 2026, at 10 am Eastern Time to discuss the results.
Earnings Release and Conference Call Details
The earnings release will be available on the company’s website following the market close on November 3. The conference call will provide management’s review of the 2026 third quarter results and current developments.
Investors can access the conference call through the following methods:
- Webcast: Recommended for participants not asking questions. Access via https://events.q4inc.com/attendee/954733075 .
- Company Website: Live stream available at https://www.omegahealthcare.com/ .
- Telephone: Dial (833) 461-5787 (toll-free) or +1 (585) 542-9983 (international). Use Meeting ID 954 733 075. Participants should dial in 15 minutes early.
Webcast replays will remain available on Omega’s website for approximately two weeks after the call. The earnings release will also be posted in the "Financial Information" section of the Investors page.
About Omega Healthcare Investors
Omega is a real estate investment trust investing in the long-term healthcare industry. Its portfolio includes skilled nursing, assisted living, and care home facilities across the U.S., U.K., and Canada. Assets are operated by diverse healthcare companies under long-term triple-net leases, with an increasing portion managed through RIDEA structures.
How might Omega Healthcare Investors' Q3 2026 results reflect the ongoing impact of regulatory changes in the U.S. skilled nursing sector?
What implications could the company's performance have for the broader REIT sector given current interest rate environments and healthcare real estate valuations?
Will management provide updated guidance on the expansion of RIDEA structures and their expected contribution to future cash flows?
































